info:eu-repo/semantics/article
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
Fecha
2021-12Registro en:
Chen, Sharon C. A.; Perfect, John; Colombo, Arnaldo L.; Cornely, Oliver A.; Groll, Andreas H.; et al.; Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM; Elsevier; Lancet Infectious Diseases; 21; 12; 12-2021; 375-386
1473-3099
CONICET Digital
CONICET
Autor
Chen, Sharon C. A.
Perfect, John
Colombo, Arnaldo L.
Cornely, Oliver A.
Groll, Andreas H.
Seidel, Danila
Albus, Kerstin
Almeida, João Nobrega de
Garcia, Guillermo Manuel
Gilroy, Nicole
Lass Flörl, Cornelia
Ostrosky Zeichner, Luis
Pagano, Livio
Papp, Tamas
Rautemaa Richardson, Riina
Salmanton García, Jon
Spec, Andrej
Steinmann, Joerg
Arikan Akdagli, Sevtap
Arenz, Dorothee E.
Sprute, Rosanne
Duran Graeff, Luisa
Freiberger, Tomas
Girmenia, Corrado
Harris, Michelle
Kanj, Souha S.
Roudbary, Maryam
Lortholary, Olivier
Meletiadis, Joseph
Segal, Esther
Tuon, Felipe Francisco
Wiederhold, Nathan
Bicanic, Tihana
Chander, Jagdish
Chen, Yee-Chun
Hsueh, Po-Ren
Ip, Margaret
Munoz, Patricia
Spriet, Isabel
Temfack, Elvis
Thompson, Luis
Tortorano, Anna Maria
Velegraki, Aristea
Govender, Nelesh P.
Resumen
Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma (ie, now Moesziomyces or Dirkmeia), Rhodotorula, Saccharomyces, and Sporobolomyces (ie, ascomycetes). A considered approach to the complex, multidisciplinary management of infections that are caused by these pathogens is essential to optimising patient outcomes; however, management guidelines are either region-specific or require updating. In alignment with the One World–One Guideline initiative to incorporate regional differences, experts from diverse geographical regions analysed publications describing the epidemiology and management of the previously mentioned rare yeasts. This guideline summarises the consensus recommendations with regards to the diagnostic and therapeutic options for patients with these rare yeast infections, with the intent of providing practical assistance in clinical decision making. Because there is less clinical experience of patients with rare yeast infections and studies on these patients were not randomised, nor were groups compared, most recommendations are not robust in their validation but represent insights by use of expert opinions and in-vitro susceptibility results. In this Review, we report the key features of the epidemiology, diagnosis, antifungal susceptibility, and treatment outcomes of patients with Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon spp infections.